2019-10-31CE Approval for Rhea Autologous Bioactive Molecules Enrich System
	We are glad to announce our Rhea Autologous Bioactive Molecules Enrich System has passed CE approval in July 2019! "Rhea" is the brand new device for preparing PRP applied in ocular surface diseases, such as Dry Eye Syndrome and Corneal Ulcer. In just 5 minutes, an 18-30ml of solution is prepared automatically, with a great formulation for ophthalmic use, as well as wound care app...
	MORE>>

	2015-04-22CE Mark Approval of the Phoenix autologous PRP collection System
	Phoenix autologous PRP collection System received CE certificate issued on 2015-03-19. With this approval, Safetran will start to launch Phoenix system in Europe.
	MORE>>

	2014-07-31Safetran exhibits at the 2014 MEDICA , the World Forum for Medicine
	Please come visit us to know more about our qualified blood transfusion service and management. We are excited to present the following products at this year : -       PHOENIX Blood Components Apheresis -       Plasma Apheresis and management. -       Cell Washer management -    &nbs...
	MORE>>

	2011-05-11Safetran Biomedical website launched at June 1st
	Safetran biomedical website launched at 1 of June 2011.
	MORE>>